The Promise of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders

by Elaine A. Moore, Samantha Wilkinson

Overview

Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS).

Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.

Product Details

ISBN-13:	9780786437153
Publisher:	McFarland & Company, Incorporated Publishers
Publication date:	12/15/2008
Series:	McFarland Health Topics
Pages:	223
Sales rank:	542,161
Product dimensions:	5.90(w) x 8.90(h) x 0.60(d)
Age Range:	18 Years

About the Author

Elaine A. Moore has worked in hospital laboratories for more than 30 years, primarily in immunohematology and toxicology. She is a freelance medical writer and laboratory consultant. For more information, visit her website at www.elaine-moore.com. She lives in Sedalia, Colorado. Samantha Wilkinson is a patient advocate for multiple sclerosis and LDN. Through her website www.ldners.org she educates patients about current LDN research. She lives in Edmonds, Washington.

Table of Contents

Table of Contents

Acknowledgments     
Foreword by Yash Pal Agrawal, M.D., Ph.D.     
Preface     
Introduction     

1. The War on Drugs—A History of Naltrexone     
2. LDN in Autoimmune Diseases     
3. LDN in Multiple Sclerosis     
4. LDN in Neurodegenerative Disorders     
5. LDN in Cancer     
6. LDN in Autism Spectrum Disorders     
7. LDN in Wound Healing and Infections     
8. The Immune System and LDN in HIV/AIDS     
9. The LDN Experience: A Patient’s Guide to LDN     
10. The Potential Benefits and Future of LDN     

Chapter Notes     
Glossary     
Appendix: Clinical Trials of LDN and Related Compounds     
Resources     
Index     

Editorial Reviews

fascinating...very well researched...is a convincing and compelling medical textbook”—Suite101.com.

From the Publisher

fascinating...very well researched...is a convincing and compelling medical textbook

Suite101.com